Back to Search Start Over

Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.

Authors :
Rudin CM
Salgia R
Wang X
Hodgson LD
Masters GA
Green M
Vokes EE
Rudin, Charles M
Salgia, Ravi
Wang, Xiaofei
Hodgson, Lydia D
Masters, Gregory A
Green, Mark
Vokes, Everett E
Source :
Journal of Clinical Oncology; 2/20/2008, Vol. 26 Issue 6, p870-876, 7p
Publication Year :
2008

Details

Language :
English
ISSN :
0732183X
Volume :
26
Issue :
6
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
105862226
Full Text :
https://doi.org/10.1200/JCO.2007.14.3461